Table I.
Formulation | Drug | Polymer(s) | Plasticizer | HME T (°C) | Print T (°C) |
---|---|---|---|---|---|
1 | 30% | 50% HPC EF + 20% HPMC E5 | 150 | 185 | |
2 | 30% | 70% PEO N80 | 140 | 185 | |
3 | 30% | 65% HPC EF + 5% PEO N80 | 140 | 190 | |
4 | 30% | 60% HPMC E5 + 10% PEO N80 | 140 | – | |
5 | 30% | 40% HPC EF + 30% PEO N80 | 140 | 195 | |
6 | 30% | 40% HPMC K100 + 20% PEO N80 | 10% TPGS | 120 | – |
7 | 30% | 40% HPMC K100 + 30% PEO N750 | 155 | – | |
8 | 30% | 45% HPC HF + 25% PEO N750 | 130 | 185* | |
9 | 30% | 20% RS PO + 20% RL PO +30% PEO N750 | 140 | – | |
10 | 30% | 60% HPC EF + 10% PEO N80 | 130 | 185 | |
11 | 30% | 20% RS PO + 20% RL PO +27.5% PEO N750 | 2.5% TEC | 100 | 165 |
12 | 30% | 40% HPC HF + 30% L100 | 130 | 170 | |
13 | 30% | 40% HPC HF + 30% E PO | 130 | 175 |
HME hot-melt extrusion, T temperature
*Formulation 8 showed day-to-day variability regarding the printability and should therefore be considered as non-printable